Enanta Pharmaceuticals Inc (ENTA)

[willyw]

I am trying to understand the benefit of not providing clarity on prescriptions.

At first I thought that I could understand; if one could compare, then one would see Viekira was clearly lower, thus affecting SP.
(a hypothetical 10%)

However, the lack of transparency seems to make it appear far worse than it is. (appearing to be 3% instead of an actual count)

I don't think I am wrong about this, but anyone, please correct this misapprehension.

I understand that many of the government type enrolling will take some time; the VA, medicaid, prison, etc.

I have even wondered if Abbvie is trying to drive down ENTA share price for a buyout, pending 2nd gen trial prelim readouts.

Where exactly is the benefit in shielding the prescriptions?
(Royalty payments to ENTA divided by computations on prescription numbers and thus the ability to derive discounts?)